| LDK378 |
| 5-Chloro-N2-[2-isopropoxy-5-methyl-4-(4-piperidinyl)phenyl]-N4-[2-(isopropylsulfonyl)phenyl]-2,4-pyrimidinediamine |
| (CAS 1032900-25-6) |
 |
| Description： |
Ceritinib (trade name Zykadia) is a drug for the treatment of lung cancer.It is an ALK inhibitor. It was approved in April 2014 by the Food and Drug Administration for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC) following treatment with crizotinib.
|
| Product No. |
KT00496 |
| Product Name |
LDK378 |
| Synonyms |
|
| Formal Name |
5-Chloro-N2-[2-isopropoxy-5-methyl-4-(4-piperidinyl)phenyl]-N4-[2-(isopropylsulfonyl)phenyl]-2,4-pyrimidinediamine |
| CAS Number |
1032900-25-6 |
| Molecular Formula |
C28H36ClN5O3S |
| Formula Weight |
558.14 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
ALK inhibitor 1
ALK inhibitor 2
AP26113
ASP3026
AZD-3463
CEP-37440
CH5424802
DMH-1
|
|
